Pharma Business Week articles from July 2003

Pharma Business Week archives from July 2003

Physicians identify that ruboxistaurin improves symptoms.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Eli Lilly and Company (LLY) announced that patients with diabetic peripheral neuropathy treated with ruboxistaurin mesylate showed improvement in Clinical Global Impression (CGI) - a globally accepted...

Harris releases study on prescription drug prices, other healthcare fees.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- According to a Harris Interactive survey, the cost of prescription drugs continues to be a very hot topic with frequent reports of consumers shopping abroad (in person or on the Internet). Other...

Diversa receives DoD Chemical and Biological Defense Initiatives Fund award.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Diversa Corporation (DVSA) announced that one of its biodefense proposals has been selected to receive a $1.38 million award from the U.S. Department of Defense's Chemical and Biological Defense (CBD)...

Enterprise agreement signed with Japanese firm.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Datatrak International, Inc., announced the signing of an Enterprise Agreement with Otsuka Maryland Research Institute (OMRI). Following an extensive internal evaluation of multiple EDC vendors,...

Femring launched in U.S.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Galen Holdings, PLC, (GALN) announced the availability of Femring in the United States, the only vaginally delivered estrogen therapy to provide dual symptom control, treating both the vaginal (dryness,...

Canadian pharmacy information management firm to use HealthWeaver.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- DataLoom Solutions has announced that the company has signed a multiyear agreement to provide its HealthWeaver technology to RxCanada, Inc. RxCanada is owned by a consortium of major Canadian pharmacy...

Cooling heart attack patients studied.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- According to results of an initial safety and feasibility study, conducted at the Montreal Heart Institute (MHI) in Montreal, Quebec, Canada, mild hypothermia - cooling a patient's body temperature by a...

GeneEd releases new regulatory and compliance library.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- GeneEd, Inc., a provider of advanced e-learning solutions for the life science industry, announced it has created new e-learning content focused on regulatory and compliance practices and procedures....

Biopharmaceutical company selected for equity index.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) announced that it has been selected for the Russell 3000 Index. Additions to the Index remain in effect for one year. According to an annual survey conducted...

A technology cure may be around the corner.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- The healthcare vertical market for networking equipment and connectivity solutions is in a period of significant evolution, according to In-Stat/MDR. The high-tech market research firm reports that...

Clinical trial IT company announces two new clients.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Document Solutions Group, Inc., (DSG), a provider of clinical trial data collection software and services, announced two new clients, a multinational pharmaceutical company and a medical device company,...

New biomedical knowledge exchange solution introduced.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Constella Biomedical Informatics, a regulatory informatics business, introduced Constella Orion, a biomedical informatics knowledge exchange solution designed to support the research and development of...

HealthSTAR releases Physician Finder 2.0 for pharmaceutical product websites.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- HealthSTAR Systems, LLC, a healthcare marketing communications service provider (MCSP), announced the release of Physician Finder 2.0. The enhanced Physician Finder 2.0 now supports integrated...

Home Diagnostics launches SmartMarketing.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Home Diagnostics, Inc., (HDI) a manufacturer and marketer of diabetes management products, introduced SmartMarketing, a blood glucose monitoring category management program. Throughout the...

Report says microbial genotyping is an underserved market.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- With public attention focused on outbreaks of severe acute respiratory syndrome (SARS) and monkeypox, along with fears of bioterrorism, microbiologists are increasingly finding themselves in the...

Hispanics more likely to suffer from numerous health conditions.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- New research from ACNielsen U.S. shows that, while Los Angeles-area Hispanics are more likely than non-Hispanics to suffer from a host of health-related conditions, they are less likely to purchase...

Skyscape makes diagnosis and treatment data available for no charge.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Skyscape is making its .911 reference, which includes its "Outlines in Clinical Medicine/Medical Emergencies" (OCM/911), "Centers for Disease Control (CDC) Spotlight" information, and "The Medical...

Tactics work to increase awareness of disease, treatment options.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Pharmaceutical companies that face limited resources and wide geographical dispersion of field-based medical programs are now creating a strong infrastructure to effectively reach and educate...

Rights to Quadramet pain therapy to be reacquired by oncology firm.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Cytogen Corporation (CYTO) and Berlex Laboratories, a U.S. affiliate of Schering AG, Germany (SHR) announced an agreement whereby marketing rights held by Berlex to market Quadramet, a skeletal...

Diabetes drug reduces development of heart stent blockage.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Groundbreaking research has shown that rosiglitazone, a drug widely used by diabetes patients to lower blood sugar levels, can also prevent or dramatically reduce the development of new blockages -...

Lack of STD awareness challenges growth of diagnostic market.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Growth of diagnostic markets are directly dependent on an increasing awareness of the symptoms of sexually transmitted diseases (STDs), which in turn spur the demand for routine screening facilities....

Studies suggest that delayed clinical trials common.
July 7, 2003... 2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Upwards of 80% of clinical trials are delayed, according to separate studies conducted by CenterWatch, the McKinsey Quarterly, IBM Global Industries, and Convergence CT. The reason? Problems...

FDA approves first once-daily protease inhibitor as part of combination therapy.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has granted marketing clearance for Reyataz (atazanavir sulfate), an azapeptide protease inhibitor...

Drug being developed as countermeasure for nuclear threats.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Congressional Pharmaceutical Corporation (CPC) announced positive results from a study that demonstrated one of its genoprotective agents conferred delayed radioprotection to human endothelial cells....

Genedata and Novartis expand collaboration in anti-infectives research.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Genedata, AG, a specialist for scientifically validated software systems and solutions for the life-science industry, announced a significant extension of its collaboration with Novartis. Under...

Pixantrone added to oncology drug pipeline, merger announced.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Cell Therapeutics, Inc., (CTI, CTIC) and Novuspharma, SpA (Novuspharma) (NOV.MI, NOV IM) announced that they have signed a definitive merger agreement providing for the merger of Novuspharma into CTI....

CEO leadership top factor in building corporate reputations at pharma firm.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Johnson & Johnson leads the pack of the pharmaceutical industry's most reputable companies for CEO Leadership, according to a new Pharmaceutical Executive survey. Companies such as Johnson &...

In-line pharmaceutical market research budgets under $1 million per drug.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- In-line pharmaceutical products, those products already sold on the market, receive an average $710,000 to support market research activities, according to a new study by pharmaceutical intelligence...

Research leads to findings on a curable form of hypertension.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- New research being presented at ENDO 2003, the 85th Annual Meeting of The Endocrine Society, may lead to novel treatments for atherosclerosis, improved detection of a curable form of hypertension, and...

Strattera most promoted prescription drug to managed care pharmacy executives.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Eli Lilly & Co.'s new attention deficient hyperactivity disorder medication was the prescription drug most heavily promoted to managed care pharmacy directors during the first quarter, according to...

Genentech and Biogen announce autoimmune collaboration.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Genentech, Inc., (DNA) and Biogen, Inc., (BGEN) announced a collaboration for the research and development of a BR3 (BAFF-R) protein therapeutic currently in Biogen's pipeline. Financial terms...

Midtier pharmaceutical company signs agreement with eRT.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- eResearchTechnology (eRT), Inc., (ERES), a provider of centralized electrocardiographic (ECG) collection and interpretation services, announced that it has received an agreement for more than $1.1...

Clinical trials IT company changes name.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Advanced Systems Development, Inc., (ASD), a provider of information technology services to the clinical trials industry, announced at the 39th Annual DIA Conference that it has changed its name and...

Generex announces third quarter financial results, positive results on Oralin.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corp. (GNBT) announced financial results for its third fiscal quarter ended April 30, 2003. The company reported a net loss for the quarter ended April 30, 2003, of $2.6...

Collaboration extended for Cetrotide.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- AEterna Laboratories, Inc., (AELA) announced the extension of the existing license agreement between its subsidiary Zentaris and Serono (SEO, SRA) for worldwide marketing rights, except in Japan, for...

New guidelines adopted to help doctors ensure safe, secure Internet prescribing.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- The American Medical Association (AMA) House of Delegates adopted guidelines to help physicians safely and securely prescribe medications to patients via the Internet. The new guidelines state...

Court upholds decision on paclitaxel-coated stents.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced that the U.S. Court of Appeals for the Seventh Circuit has substantially affirmed a U.S. District Court decision in favor of Boston Scientific in its...

Medco accused of favoring Merck drugs.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Federal prosecutors said on June 23, 2003, that a company supposed to help health plans find low-cost prescription drugs instead pressured doctors to switch patients to medications made by its owner,...

Monash University takes equity in Norwood Immunology.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Norwood Abbey, Ltd., (NAL), the Melbourne-based medical technologies commercialization company, announced that its subsidiary, Norwood Immunology, has entered into a full licensing agreement with...

Microbial genetic diversity-focused company plans to liquidate its assets.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- InterLink Biotechnologies (ILB) has decided to liquidate the assets of the company due to difficulties encountered in securing a suitable merger partner to allow the company to continue to expand its...

87% of pharmaceutical firms begin thought leader programs by phase II.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Pharmaceutical companies should begin screening key opinion leader candidates as early as between phase I and phase II, according to new research from pharmaceutical intelligence firm Cutting Edge...

Global pharmaceutical launches: Marketing spends for blockbuster products.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Global budgets for new products include spending for opinion leader management, publishing, congresses, and market research, to name a few key marketing activities, according to new research by...

Media Cybernetics upgrades Gel-Pro Analyzer.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Media Cybernetics, Inc., an analytical imaging software provider, announced the upgrade release of Gel-Pro Analyzer. Gel-Pro Analyzer is designed for molecular biologists that acquire images from...

Pharmaceutical development agreement signed for ACP-103.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Amarin Corporation plc (AMRN) confirmed that its Swedish subsidiary, Amarin Development AB, has been engaged to provide pharmaceutical formulation and manufacturing services for Acadia Pharmaceuticals,...

HemoSense names Ad de Waard as director, international business development.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- HemoSense, Inc., manufacturer of the portable INRatio Prothrombin Time (PT) Monitoring System, has appointed Ad de Waard to the position of director, international business development. de Waard...

New Cath-Lab survey shows significant penetration of drug eluting stents.
July 14, 2003... 2003 JUL 14 - (NewsRx.com & NewsRx.net) -- Millennium Research Group, a provider of global medical market intelligence, announced the findings of its new Cath-Lab Marketrack survey for May 2003. Cath-Lab Marketrack monitors monthly usage of...

Biopharmaceutical company reports cancer therapy progress.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Immunomedics, Inc., (IMMU) announced that four presentations made at an annual meeting of nuclear medicine physicians and scientists indicated progress in the development and use of antibody-based...

$65M for genomics, proteomics research aimed at human health.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Allan Rock, Canadian Industry minister announced up to $65 million will be made available for a special competition on Applied Genomics and Proteomics Research in Human Health. The minister made...

Proteome annotation resource, Biopendium Online, launched.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Inpharmatica, Ltd., an informatics-driven drug discovery company, announced that Biopendium Online, a new version of its premier Biopendium annotation resource, has been launched. Biopendium...

Isis and Taiwan company initiate SARS antisense drug discovery effort.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals, Inc., (ISIS) and the Industrial and Technology Research Institute (ITRI) of Taiwan (the Republic of China), announced that they will collaborate to identify antisense drug...

Phase I CAB-175 trial commences in U.S. following IND filing.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Cubist Pharmaceuticals, Inc., (CBST) has commenced a multidose phase I trial in the U.S. for its investigational antibiotic CAB-175 following the filing of an Investigational New Drug (IND) application...

CE Mark granted for European commercialization of DuraSeal.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Confluent Surgical, Inc., announced that it has been awarded a CE Mark (product certification) allowing the commercial distribution of its DuraSeal Dural Sealant System within the European Community....

Research deal signed with Centocor on multiple proteins.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Biolex, Inc., announced the signing of a research collaboration with Centocor, Inc., a wholly owned subsidiary of Johnson & Johnson, to examine the feasibility of producing three proteins using Biolex'...

Lucy Rose, EduNeering collaborate on pharma education programs.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Lucy Rose, president of Lucy Rose and Associates, and EduNeering, Inc., a provider of global compliance learning solutions, announced their strategic collaboration to provide a series of programs and...

Key milestone reached with Blue Cross/Blue Shield coverage of the Essure.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Conceptus, Inc., (CPTS) announced its Essure procedure has received positive decisions with Blue Cross/Blue Shield plans that account for nearly 43 million covered lives, or more than one-half of all...

HDMA members pledge to protect drug supply chain.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- In an aggressive effort to protect the integrity of the pharmaceutical supply chain, the Healthcare Distribution Management Association (HDMA), whose membership represents more than 90% of the nation's...

Bioanalytical toolbox provides method development for sample preparation.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Argonaut Technologies, Inc., (AGNT) announced the introduction of the Argonaut Bioanalytical Toolbox, a comprehensive set of consumables and accessories for fast, rational pharmaceutical sample...

$3.4M in new business awarded to conduct research studies.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Covalent Group, Inc., (CVGR) announced the awarding of contracts with five different pharmaceutical companies whose corporate headquarters are located in the United States and Western Europe. ...

Diagnostics company raises additional capital.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- AMDL, Inc., (ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, announced that as of June 18, 2003, it has raised approximately $887,000, net of...

Neurovascular company completes $8.2 million preferred stock financing.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Micrus Corp. announced that the company completed the placement of $8.2 million of convertible preferred stock with an investor group led by HBM Bioventures, AG, of Switzerland. Additional...

Option exercised for additional $15M by immunotherapeutics firm.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Corixa Corporation (CRXA) announced that the initial purchaser for its recent offering of 4.25% convertible subordinated notes due 2008 has exercised its option to purchase an additional $15 million in...

Private placement investment of $3M in convertible notes.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Adherex Technologies, Inc., (AHX) announced that it has closed a private placement of convertible notes totaling approximately CDN$3.0 million. More than 70% of the subscriptions came from...

Revised second quarter earnings outlook, merger announced by biotech firm.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Biogen, Inc., (BGEN) reconfirmed operating earnings per share guidance for full year 2003 of $1.72 to $1.85 and announced that the company will merge with IDEC Pharmaceuticals, Inc. Biogen...

Program aggressively promotes generic education and utilization.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- A new program for health plans and employers called Win With Generics encourages consumers to request and physicians to prescribe generic drugs. Blue Cross and Blue Shield of Kansas will be the...

Consumers see great promise in biotechnology.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Although nearly 80% of consumers can't name a biotechnology company or product, the same number believe biotechnology will treat cancer, replace or repair damaged tissue, and be the primary source of...

Creative strategies can sustain growth in blood pressure monitors market.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- The increasing incidence of high blood pressure among the American population and the fact that blood pressure measurement is a vital statistic in determining overall health, are driving interest in...

Research process offers platforms for future product introductions.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Ziment has launched Messagez, the latest addition to its suite of market research approaches for product and business development managers launching and repositioning products in the pharmaceutical,...

Meridian signs letter of intent to acquire telemedicine company.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Meridian Co., Ltd., (MRDAF) announced that the company has signed a letter of intent with Bionet, a developer, manufacturer, and distributor of patient monitoring and fetal monitoring systems in Korea....

Point Technologies enters license agreement.
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Point Technologies, Inc., and Incyte Corp. announced an agreement under which Point Tech has sublicensed U.S. patent no. 5,807,522, "Methods for Fabricating Microarrays of Biological Samples," issued...

Venture capital firm releases findings from "The Nanotech Report 2003".
July 21, 2003... 2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Lux Capital, a venture capital firm focused on nanotechnology, announced the release of key findings from "The Nanotech Report 2003," a more-than 500-page research report. Among the findings: ...

International HIV vaccine trial under way in Africa and the United States.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- St. Louis University is leading an international vaccine trial to study a promising HIV prevention vaccine in humans. The trial is being conducted through the HIV Vaccine Trials Network (HVTN) of the...

Enrollment commences in pivotal ARISE phase III trial of AGI-1067.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX) has begun enrollment of patients in its pivotal ARISE phase III clinical trial of AGI-1067, a novel oral anti-inflammatory agent targeting atherosclerosis, the disease that...

Randomized phase IIb study of Pivanex in lung cancer initiated.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- Titan Pharmaceuticals, Inc., (TTP) announced the initiation of a multicenter, randomized, controlled, phase IIb clinical trial with its novel drug Pivanex in the treatment of advanced non-small cell...

Company announces Proxis trial, distribution agreement, and financing.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- Velocimed, Inc., a developer and manufacturer of medical devices used in the treatment of cardiological and neurological diseases, announced that it has received U.S. Food and Drug Administration (FDA)...

Medtronic enters collaboration with Israeli company.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- Medtronic, Inc., (MDT) announced it has completed an equity investment in MindGuard, Ltd., a privately held developer of devices for high-risk stroke patients. As part of the agreement, Medtronic...

U.S. enrollment initiated in phase III study of dexanabinol.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- Pharmos Corporation (PARS) announced that U.S. enrollment has commenced in its phase III study of dexanabinol for traumatic brain injury (TBI), ongoing in more than 60 international centers where more...

Enrollment begins for phase I trial of SAHA.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- Aton Pharma, Inc., announced that enrollment has begun in a phase I clinical trial of SAHA in patients with advanced leukemias, including acute myeloid leukemia (AML), chronic myeloid leukemia (CML),...

Seven orders received for bioarchive systems in fourth quarter.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- ThermoGenesis Corp. (KOOL) announced that the company received orders for five BioArchive Systems in June bringing to seven the total number of orders received in the fourth quarter. The seven...

VaxGen to complete phase III trial in Thailand.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc., (VXGN) has issued a response to several newspaper articles that inaccurately stated that the company was planning to withdraw from its phase III trial in Thailand. According to the...

Pharmaceutical firm initiates actions to improve profitability.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- Baxter International, Inc., (BAX) announced several measures to position the company more competitively and to enhance its long-term profitability. The company plans to close 26 plasma collection...

Generic biopharmaceuticals to hit market over next several years.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- Over the next few years, a number of first-generation biopharmaceuticals will come off patent and lose marketing exclusivity, according to the Strategic Research Institute. These include several...

Biotech continues to show strength in June.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- "Although investor enthusiasm leveled off in June with little investor reaction to yet another 0.25% cut in interest rates and continuing predictions of a slow global recovery, the biotech market...

Pharma leaders cut years off drug development time.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- Pharmaceutical companies sliced almost 2 years off high-priority products' development time, according to a new report by pharmaceutical intelligence firm Cutting Edge Information. Streamlined...

Pharmacist shortage continues unabated.
July 28, 2003... 2003 JUL 28 - (NewsRx.com & NewsRx.net) -- The National Association of Chain Drug Stores Foundation latest pharmacist employment survey found 5499 vacant chain pharmacy positions as of January 2003. With retail pharmacies expected to fill...